Maverick Citizen Excitement builds for long-acting TB treatments, but research still at early stage 5 min 0 By Catherine Tomlinson
Maverick Citizen Competition law has again worked to fight a bad drug patent, but we need other solutions 6 min 0 By Fatima Hassan and Leena Menghaney for Spotlight
Maverick Citizen Faster tests, shorter treatments — how new tech could help slow down drug-resistant TB 6 min 1 By Zano Kunene
Maverick Citizen More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws 5 min 7 By Mia Malan for the Bhekisisa Centre for Health Journalism
Maverick Citizen #SliceOfLife – how I beat a rare form of TB, but lost my hearing 3 min 0 By Nicole Ludolph
Maverick Citizen Is the future of South Africa’s TB plans locked up in the mysterious minds of teens? 7 min 0 By Joan van Dyk for the Bhekisisa Centre for Health Journalism
Maverick Citizen Shorter, simpler drug-resistant TB treatment expected in SA later in 2022 6 min 0 By Catherine Tomlinson
Maverick Citizen Minimising nasty side effects: Important TB drug is effective at lower dose, study finds 7 min 0 By Tiyese Jeranji and Marcus Low for Spotlight
South Africa Survivors and activists demand increased action against TB 4 min 0 By Amy Green for Health-e news
South Africa Drug-resistant TB breakthrough as new drug approved for use in United States after SA trials 6 min 0 By Spotlight
South Africa Support South Africa at UN – we need better & affordable TB medicines 5 min 0 By Sibongile Tshabalala and Umunyana Rugege
South Africa New tuberculosis drugs are more effective and may be less toxic. Why are they still unavailable? 6 min 0 By Marelise Van Der Merwe
